Related Experiment Video
Updated: Jul 10, 2025
05:55
Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
567
UNDERSTANDING THE LONG-TERM INTERPLAY BETWEEN GLUCOCORTICOIDS, PARATHYROID HORMONE LEVELS, AND OSTEOPOROSIS IN
11Department of Community Medicine, Parul University, PO Limda, Tal.Waghodia, District Vadodara, Gujarat, India.
Georgian Medical News
|November 22, 2023
Summary
Long-term glucocorticoid (GC) use is linked to osteoporosis. This study found higher parathyroid hormone (PTH) levels in GC users with osteoporosis, suggesting PTH as a marker for bone issues.
Area of Science:
- Endocrinology
- Pharmacology
- Bone Metabolism
Background:
- Glucocorticoids (GCs) are widely used for their anti-inflammatory properties.
- Long-term or high-dose GC use can lead to adverse effects, including bone density loss.
- Osteoporosis (OP) is a significant health concern associated with GC therapy.
Purpose of the Study:
- To investigate the relationship between long-term glucocorticoid use and osteoporosis.
- To assess parathyroid hormone (PTH) and calcium (Ca) levels in patients with GC-induced osteoporosis.
- To identify potential biomarkers for predicting bone mineral abnormalities in GC users.
Main Methods:
- A case-control study was conducted with 100 participants (50 osteoporosis patients, 50 controls).
- Participants were matched for age and gender.
- Blood levels of parathyroid hormone (PTH) and calcium (Ca) were measured and compared between groups.
Main Results:
- Osteoporosis patients exhibited significantly higher parathyroid hormone (PTH) levels compared to the control group.
- Calcium (Ca) levels were significantly lower in the osteoporosis patient group.
- A positive correlation was observed between PTH levels and the condition of bone mineralization.
Conclusions:
- Elevated PTH levels are associated with osteoporosis in long-term glucocorticoid users.
- PTH may serve as a prognostic marker for detecting bone mineral abnormalities in patients on chronic GC therapy.
- Monitoring PTH could aid in the early prediction and management of GC-induced bone complications.
More Related Videos
Related Concept Videos
01:40Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
01:17Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
01:21Skeleton and Calcium Homeostasis
4.6K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.6K
00:59The Parathyroid Glands
2.1K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
2.1K
01:29Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
01:31Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K